Zinaida Good
- Molecular Biology top 10%
- Oncology top 5%
- Immunology top 5%
- Genetics top 10%
- Biomedical Engineering
- Co-authors
- Garry P. NolanNikolay SamusikKara L. DavisMatthew H. SpitzerCrystal L. MackallRobert T. BrookeSteve HorvathMichael D. Leipold
- Topics
- CAR-T cell therapy research (8 papers)Single-cell and spatial transcriptomics (5 papers)Cancer Genomics and Diagnostics (3 papers)
- Cited by
- AgingOncologyBiophysics
- Partner nations
- United StatesItalyAustralia
In The Last Decade
Zinaida Good
13 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Molecular Biology 711
- Oncology 707
- Immunology 455
- Genetics 195
- Biomedical Engineering 188
Countries citing papers authored by Zinaida Good
This map shows the geographic impact of Zinaida Good's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zinaida Good with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zinaida Good more than expected).
Fields of papers citing papers by Zinaida Good
This network shows the impact of papers produced by Zinaida Good. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zinaida Good. The network helps show where Zinaida Good may publish in the future.
Co-authorship network of co-authors of Zinaida Good
This figure shows the co-authorship network connecting the top 25 collaborators of Zinaida Good. A scholar is included among the top collaborators of Zinaida Good based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zinaida Good. Zinaida Good is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapybreakdown → | 93 |
| 5 | 3 | |
| 6 | 57 | |
| 7 | 2 | |
| 8 | Reversal of epigenetic aging and immunosenescent trends in humansbreakdown → | 310 |
| 9 | 38 | |
| 10 | c-Jun overexpression in CAR T cells induces exhaustion resistancebreakdown → | 514 |
| 11 | 4 | |
| 12 | 1 | |
| 13 | 85 | |
| 14 | 262 | |
| 15 | 53 | |
| 16 | 36 |
About Zinaida Good
Zinaida Good is a scholar working on Biophysics, Oncology and Immunology, having authored 16 papers that have together received 1.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Single-cell and spatial transcriptomics (5 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Aging (65 citations), Oncology (707 citations) and Biophysics (125 citations). Zinaida Good has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Garry P. Nolan, Nikolay Samusik, Kara L. Davis, Matthew H. Spitzer, Crystal L. Mackall, Robert T. Brooke, Steve Horvath, Michael D. Leipold, Gregory M. Fahy and Holden T. Maecker. Their work appears in journals such as Nature, New England Journal of Medicine and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.